ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,045,488 | +121.7% | 696,228 | +98.6% | 0.00% | – |
| Q3 2022 | $6,787,000 | -76.0% | 350,544 | -75.4% | 0.00% | -100.0% |
| Q2 2022 | $28,287,000 | +4.4% | 1,424,343 | +56.7% | 0.00% | +100.0% |
| Q1 2022 | $27,107,000 | +17.2% | 908,728 | -8.5% | 0.00% | 0.0% |
| Q4 2021 | $23,123,000 | -29.7% | 992,832 | -5.9% | 0.00% | -50.0% |
| Q3 2021 | $32,913,000 | +10.7% | 1,054,911 | +24.8% | 0.00% | 0.0% |
| Q2 2021 | $29,744,000 | -15.8% | 845,483 | -15.6% | 0.00% | 0.0% |
| Q1 2021 | $35,309,000 | +20.4% | 1,001,660 | +28.1% | 0.00% | 0.0% |
| Q4 2020 | $29,324,000 | +292.9% | 781,765 | +249.6% | 0.00% | +100.0% |
| Q3 2020 | $7,463,000 | +24.3% | 223,648 | -1.3% | 0.00% | – |
| Q2 2020 | $6,003,000 | +66.8% | 226,624 | +3.1% | 0.00% | – |
| Q1 2020 | $3,600,000 | -26.9% | 219,915 | +13.6% | 0.00% | – |
| Q4 2019 | $4,922,000 | +26.4% | 193,626 | -0.6% | 0.00% | – |
| Q3 2019 | $3,895,000 | -31.5% | 194,752 | +10.4% | 0.00% | – |
| Q2 2019 | $5,688,000 | +24.3% | 176,412 | +24.1% | 0.00% | – |
| Q1 2019 | $4,577,000 | +34.1% | 142,108 | +2.1% | 0.00% | – |
| Q4 2018 | $3,414,000 | -29.1% | 139,167 | -4.8% | 0.00% | – |
| Q3 2018 | $4,817,000 | -3.4% | 146,180 | +4.2% | 0.00% | – |
| Q2 2018 | $4,984,000 | – | 140,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |